pharmaceutically

The invention provides pharmaceutically acceptable esters, salts, and prodrugs thereof.

本发明提供了药学可接受的酯类、盐类及其前体药物。

Disclosed are the ERK inhibitors of Formula (1.0) : and the pharmaceutically acceptable salts and solvates thereof.

所公开的是式(1.0)的ERK抑制剂；及其药学上可接受的盐和溶剂合物。

The formulations include a pharmaceutically acceptable carrier or are provided as part of a medical device or coating.

所述制剂包含可药用载体，或者以医用装置的一部分或涂层的形式提供。

The composition further comprises a surfactant and optionally one or more other pharmaceutically acceptable excipients.

该组合物还包含表面活性剂，以及任选的一种或多种其他可药用的赋形剂。

Also disclosed are pharmaceutical compositions comprising a compound of the invention and a pharmaceutically acceptable carrier.

还透露，均由一发明化合物和药学上可接受的载体药物成分。